Chandigarh, India

Manisha Kumari

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manisha Kumari. Retrieved from https://idiyas.com/inventor/manisha-kumari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manisha Kumari: Innovator in Peptide-Based Inhibitors

Introduction

Manisha Kumari is a distinguished inventor based in Chandigarh, India. He has made significant contributions to the field of biochemistry, particularly in the development of peptide-based inhibitors. His innovative work focuses on addressing amyloid-related disorders, which are critical in the realm of medical research.

Latest Patents

Manisha Kumari holds a patent for "Potent peptide inhibitors of protein aggregation." This patent presents a novel peptide that acts as a potent inhibitor of protein aggregation. The peptide is characterized by the general Formula 1, [XSACX]HHHH[XXCGG](SEQ ID NO. 9). The components of this formula include an acetyl group, a hydrophilic polar uncharged amide group containing amino acids, and specific amino acids such as His or Leu, and His or Ser. This innovative peptide is particularly useful in the treatment of amyloid-related disorders.

Career Highlights

Manisha Kumari is affiliated with the Council of Scientific and Industrial Research, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic approaches to complex diseases.

Collaborations

Some of his notable coworkers include Deepak Kumar Sharma and Arpit Gupta. Their collaborative efforts contribute to the ongoing research and innovation within their field.

Conclusion

Manisha Kumari's contributions to peptide-based inhibitors represent a significant advancement in the treatment of amyloid-related disorders. His innovative approach and dedication to research continue to inspire progress in biochemistry and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…